Shannon Wiley focuses her practice on healthcare regulatory and transactional matters with a specific emphasis in the pharmaceutical industry. Shannon provides clients with legal guidance steeped in a deep business understanding, such as assisting clients with the development of limited distribution networks, pharmacy services agreements, hub arrangements, data services arrangements, and GPO agreements. She advises clients on regulations such as the Anti-Kickback Statute, the Health Insurance Portability and Accountability Act (HIPAA), the Civil Monetary Penalty Law, and FDA regulations such as the Drug Supply Chain Security Act. Shannon also provides guidance on the healthcare regulatory aspects of mergers and acquisitions.
American Health Lawyers Association (AHLA)
National Association of Specialty Pharmacies (NASP)
American Pharmacists Association (APhA)
Memphis Bar Association — Health Law Section, Chair (2019) and Board Member (2015-2019); CLE Committee, Chair (2015-2016)
We represented HealthTrust (Healthtrust Purchasing Group, L.P.) in its definitive agreement to acquire Resource Optimization & Innovation (ROi), a recognized leader in healthcare supply chain management.
Represented Consonance Capital Partners in the recapitalization of Orsini Pharmaceutical Services, LLC
Represented Community Pharmacy Partners in its investment by Altaris Capital Partners, LLC.
Served as lead healthcare regulatory counsel to Amazon (Nasdaq: AMZN) in its acquisition of PillPack
Provided healthcare regulatory and antitrust counsel to Avella Specialty Pharmacy in its sale to OptumRx
Represented Fred’s, Inc. in its sale of EntrustRx to CVS Health Corporation.
Represented Medical Specialties Distributors (MSD) to McKesson Corporation.
Represented a leading provider of 340B Drug Pricing Program services in its acquisition by a prescription benefit management subsidiary of a leading pharmacy healthcare provider
Represented Frazier Healthcare Partners in its acquisition of a specialty pharmacy platform
Assisted a biopharmaceutical manufacturer with a limited distribution network oncology drug launch
Mid-South Super Lawyers “Rising Star” (2013-2018)
Cecil C. Humphreys Law Review